JACKLYN JUMP: Open Payments
NPI 1568802775 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 13 payments from 7 companies in 2025. Trend: 2023 $395 · 2024 $1,673 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $151 |
| ConvaTec Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $37 |
| Astellas Pharma US Inc | 1 | $23 |
| Sagent Pharmaceuticals | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| COLOPLAST CORP | 1 | $18 |
Products named: ORGOVYX, GEMTESA, GENTLECATH, JARDIANCE, Xtandi, Glydo, Cologuard Collection Kit, SpeediCath.
Industry payments across CA — which companies pay providers there.
